Diabetes Technology

Feature Archive

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

Latest

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

Continuous Glucose Monitoring Cost-Effective in Type 1 Diabetes

For adults with type 1 diabetes with suboptimal control despite using multiple insulin injections, continuous glucose monitoring seems cost-effective, with improved glucose control.

Pharmacists Can Help With Diabetes Management via Telemedicine

Pharmacists Can Help With Diabetes Management via Telemedicine

Telemedicine could provide real-time feedback loop and allow pharmacists to help patients self-manage.

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

Risks and Benefits of FDA "Pre-Cert" Program for Medical Software Devices Examined

The FDA Digital Health Software Precertification Program represents a feasible solution to regulate software classified as a medical device.

FDA Approves Unique Device for Diabetic Retinopathy Screening

FDA Approves Unique Device for Diabetic Retinopathy Screening

This is the first device authorized for marketing that provides a screening decision without the need for clinician interpretation.

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

New 'Smart' CGM System Provides Predictive Alerts to Patients With Diabetes

Users also have access to the Company's Sugar.IQ app, which uses IBM's Watson Health platform, to identify glucose patterns based on factors that may affect them (ie, food intake, insulin dosages, daily routines).

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed

Researchers assessed the safety and accuracy of an implantable continuous glucose measurement in adults diagnosed with type 1 and type 2 diabetes.

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

Dexcom G6 Integrated Continuous Glucose Monitoring System Gets FDA Approval

The FDA reviewed data for the device through the de novo premarket review pathway, a regulatory pathway for novel, low-to-moderate-risk devices that are not substantially equivalent to an already legally marketed device.

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D

For pregnant women with type 1 diabetes, a closed-loop system is associated with comparable glucose control and significantly less hypoglycemia than sensor-augmented pump therapy.

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

MiniMed 670G System Improves Glycemic Outcomes in Children With T1D

Research findings indicate improved glycemic outcomes in children with T1D using the MiniMed 670G system, similar to those observed for adolescents and adults.

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend to youth with T2D.

Sign Up for Free e-Newsletters

CME Focus